Hostname: page-component-76fb5796d-vfjqv Total loading time: 0 Render date: 2024-04-25T14:26:42.419Z Has data issue: false hasContentIssue false
  • English
  • Français

Dissolving the Problem of Infectious Medical Waste

Published online by Cambridge University Press:  02 January 2015

Sue Crow
Sue Crow*
Affiliation:
Louisiana State University and Medical Center Hospital, Shreveport, Louisiana
*
Louisiana State University Medical Center, PO Box 33932, Shreveport, LA 71130
Get access Rights & Permissions [Opens in a new window]

Abstract

Decisions in purchasing healthcare products are based on fiscal responsibility, employee safety, regulatory agency guidelines, and environmental conservation. One of today's major dilemmas in health care is that of disposing of medical waste. The Isolyser Company of Norcross, Georgia, is one of the first to develop a biocycle system to reduce the problem of contaminated waste. A description of the system is provided, along with its advantages and disadvantages.

Type
Product Commentary
Information
Infection Control & Hospital Epidemiology , Volume 17 , Issue 7 , July 1996 , pp. 434 - 437
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1996

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.French, HM. Blueprint for reducing, reusing, recycling. AORN J 1994;69:94–98.Google Scholar
2.Rutala, WA, Sarubbi, FA. Management of infectious waste from hospitals. Infect Control 1983;4:198–204.Google Scholar
3. In-vitro biological reactivity using MEM Elution. Fairfield, NJ: United States Testing Company, Inc; July 22, 1993.Google Scholar
4.Isolyser Company, Inc. Characteristics of OREX Degradables and Competitive Products. Norcross, GA: MedSurg, an Isolyser Company; June 1994.Google Scholar
5.Intracutaneous Injection (mice) and Systemic Injection (rabbits). Fairfield, NJ: United States Testing Company, Inc; July 22, 1993.Google Scholar
6. 96-Hour Acute Toxicity Test on OREX Fabric with Fathead Minnows; 48-Hour Acute Toxicity Bioassay Ceriodaphnia dubia. Fairfield, NJ: Shealy Environmental Service, Inc. November 1991.Google Scholar
7.Isolyser Company, Inc. OREX Degradables System, Skin Sensitization Test. Norcross, GA: MedSurg, an Isolyser Company, Inc; July 1994.Google Scholar
8.Isolyser Company, Inc. OREX Degradables System, Vaginal Mucosal Sensitivity Studies. Norcross, GA: MedSurg, an Isolyser Company, Inc; July 1994.Google Scholar
9.Suzuki, T, Ichihara, Y, Yamada, M, Tonomura, K. Agricultural & Biological Chemistry. 1975;39:2447–2448.Google Scholar
10.Watanabe, Y, Morita, M, Hamada, N, Tsujisaka, Y. Purification and properties of a polyvinyl-alcohol degrading enzume produced by a strain of Pseudomonas. Arch Biochem Biophys 1976;174:575–581.Google Scholar
11. Alcohol Repellency. Fairfield, NJ: United States Testing Company, Inc. April 6, 1994.Google Scholar
12. Water Resistance. United States Testing Company, Inc. April 6, 1994.Google Scholar
13.Moisture vapor transmission. Fairfield, NJ: United States Testing Company, Inc. May 31, 1994.Google Scholar
14.Association for the Advancement of Medical Instrumentation. Selection of Surgical Gowns and Drapes in Health Care Facilities (AAMI TIR No. 11-1994). Arlington, VA: AAMI, Inc. July 25, 1995.Google Scholar